07/25/2025 4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2025 4:17 PM | Calidi Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/15/2025 7:42 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2025 7:42 PM | Calidi Biotherapeutics (Issuer) Peoples George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2025 7:42 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2025 7:42 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2025 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
07/11/2025 4:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2025 12:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2025 12:20 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
07/10/2025 12:20 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for CLDI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
07/03/2025 4:27 PM | Calidi Biotherapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/15/2025 2:14 PM | ARMISTICE CAPITAL, LLC (Filed by) Calidi Biotherapeutics (Subject)
| Form SCHEDULE 13G | |
05/14/2025 3:45 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025 3:30 PM | Calidi Biotherapeutics (Filer)
| Form PRE 14A | |
05/02/2025 3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2025 5:01 AM | Calidi Biotherapeutics (Issuer) Poma Eric E (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/25/2025 5:05 AM | Calidi Biotherapeutics (Issuer) Poma Eric E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2025 7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2025 8:57 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 5:07 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2025 3:52 PM | Calidi Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/31/2025 5:00 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
03/10/2025 4:21 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/10/2025 4:28 PM | Calidi Biotherapeutics (Filer)
| Form 8-K/A | |
02/09/2025 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
02/05/2025 5:27 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/28/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 3:58 PM | Calidi Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/10/2025 3:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/10/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:01 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/03/2025 4:25 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 4:27 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2024 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
12/18/2024 8:29 PM | Calidi Biotherapeutics (Issuer) Camaisa Allan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 5:13 AM | Calidi Biotherapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/29/2024 4:00 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/18/2024 7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 4:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Is this the biggest winner of Trump’s tariffs? (Ad) America’s industrial comeback is underway — and it’s bigger than anyone expected.
Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam.
But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most. This could be the #1 America First stock of the decade. |
11/15/2024 5:03 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/14/2024 5:21 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/12/2024 4:08 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024 9:05 AM | Calidi Biotherapeutics (Subject) NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/24/2024 4:18 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 8:38 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2024 7:25 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/18/2024 4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 4:29 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Peoples George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2024 4:05 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
09/30/2024 5:53 PM | Calidi Biotherapeutics (Issuer) Camaisa Allan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 8:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 5:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:12 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 3:04 PM | Calidi Biotherapeutics (Subject) Funicular Funds, LP (Filed by)
| Form SC 13G | |
08/22/2024 4:16 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 5:04 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 4:10 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024 8:15 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |